Stine Marit Moen

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Cecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch et al. · Frontiers in Neurology · 2021 · 94 citations · Full text

25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

Trygve Holmøy, Stine Marit Moen, Thomas E. Gundersen et al. · Multiple Sclerosis Journal · 2009 · 82 citations

Translational Medicine, Neurological Disorder, Cerebrospinal Fluid +12

Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome

Stine Marit Moen, Elisabeth Gulowsen Celius, Leiv Sandvik et al. · Neurology · 2011 · 68 citations

The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis

Cecilia Smith Simonsen, Heidi Øyen Flemmen, Trine Lauritzen et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2020 · 63 citations · Full text

Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study

Marte W. Gustavsen, Christian M. Page, Stine Marit Moen et al. · BMC Neurology · 2014 · 58 citations · Full text